The world's first: Our country achieves regenerative islet transplantation, opening a new path for diabetes treatment.

2026-03-29 03:26:06

A reporter from the Excellence Innovation Center for Molecular Cell Science of the Chinese Academy of Sciences (Institute of Biochemistry and Cell Biology) learned that the research team led by Cheng Xin at the center, in collaboration with Professor Yin Hao’s team from the Second Affiliated Hospital of Naval Medical University (Shanghai Changzheng Hospital), recently achieved, for the first time internationally, minimally invasive transplantation of regenerated islets (E-islets) derived from both autologous and allogeneic stem cells. This has led to the reconstruction of islet function and autonomous blood sugar regulation in patients with type 1 diabetes. The related results have been published online in the international academic journal “The Lancet Diabetes & Endocrinology.” (CCTV News)

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes